American Board of Internal Medicine home page

Initial Certification indicates that physicians have met rigorous standards through intensive study, accredited training and evaluation and that they have the clinical judgment, skills and attitudes essential for the delivery of excellent patient care.

MOC is a professionally determined standard that attests that an internist is staying current in knowledge and practice throughout his/her career.

For more than 75 years, Certification by ABIM has stood for the highest standard in internal medicine and its 20 subspecialties.

Hematology Board

Mark M. Udden, MD, Chair

Dr. Udden, a board certified hematologist and internist, is Chief of Benign Hematology and Professor of Medicine at Baylor College of Medicine (BCM) in Houston, Texas. He is Chief of Hematology at the Ben Taub General Hospital and Harris Health Smith Clinic. He is also an Attending Physician in the Baylor Clinic and consults at Baylor Saint Luke's Medical Center and the Texas Children's Hospital Pavilion for Women. He has a special interest in sickle cell disease and hematology of pregnancy. He also co-chairs the second-year medical student course in hematology/oncology and has an active teaching role for resident and fellowship training at Baylor.

He has served at Baylor as Core Clerkship Director for Internal Medicine from 1990 to 2007 and Chairman of the Longitudinal Ambulatory Care Experience course from 1994 to 1999. He was an adjunct Assistant then Associate Professor in the Biomedical Engineering Department at Rice University from 1983 until 1992.

Dr. Udden is Chair of the American Board of Internal Medicine (ABIM) Hematology Board. He is also Chair of the ABIM Hematology Board Exam Committee. He is a fellow of the American College of Physicians. At Baylor, he has received numerous teaching awards including the Barbara and Corbin J. Robertson, Jr. Presidential Award for Excellence in Education in 2008 and the Master Clinician Lifetime Award in 2013.

He received his undergraduate degree from the Massachusetts Institute of Technology and his medical degree from The University of Texas Southwestern Medical School. He completed his residency in internal medicine and a fellowship in hematology at Baylor College of Medicine.

As of January 2017, Dr. Udden reported the following external relationships:

Funding for clinical trial salary support, paid to Baylor College of Medicine, from the following company:

  • Sanofi, for a trial of leukine in dementia.

Diane S. Blum

Ms. Blum is a health care consultant with expertise in psychosocial care of the cancer patient, oncology research and education, and non-profit management.

Through 2013, she served as Chief Executive Officer of the Lymphoma Research Foundation, the nation's largest non-profit organization devoted to funding lymphoma research and providing education about the disease. Previously, for 20 years, Ms. Blum was Executive Director of CancerCare, a national non-profit support organization for people with all cancers. Before serving as executive director, she had been Director of Social Service at CancerCare and a Social Work Supervisor at Memorial Sloan Kettering Cancer Center and the Dana-Farber Cancer Institute.

Ms. Blum is a founder of National Breast Cancer Awareness Month, and for 12 years, served as Editor-in-Chief of Cancer.net, the American Society of Clinical Oncology (ASCO) website for patients and the public. She is a member of the American Board of Internal Medicine Hematology Board. She has served on committees of the Institutes of Medicine, ASCO and National Cancer Institute, and is on editorial boards of five oncology publications. Ms. Blum's awards include the Lifetime Achievement Award from the Board of Sponsors of National Breast Cancer Awareness Month, the Special Recognition Award from the National Coalition for Cancer Survivorship, the Republic Bank Breast Cancer Research Award, the ASCO Special Recognition Award and the 2009 ASCO Partners in Progress Award. This award recognized Ms. Blum's leadership in helping patients overcome the financial, educational, and emotional burdens that accompany a cancer diagnosis.

Ms. Blum received a bachelor's degree from the University of Rochester and a master's degree from the School of Social Welfare at the University of Buffalo.

As of January 2017, Ms. Blum reported the following external relationships:

  • Cystic Fibrosis Foundation, receiving reimbursement for travel expenses and consulting fees for working with their leadership to make changes in the service program of the organization.

Gerardo Colon-Otero, MD

Dr. Colon-Otero, who is board certified in Hematology, Medical Oncology and Internal Medicine, is the Associate Dean, Mayo Medical School, Florida campus; Associate Professor, Mayo Clinic College of Medicine; and Director of Health Disparities Research, Mayo Clinic in Florida. Dr. Colon-Otero currently practices hematology and medical oncology at the Mayo Clinic in Florida where he served as Chair of the Division of Hematology/Oncology for 15 years. He has served as founding Director of the Hematology/Oncology Fellowship Program and Associate Program Director of the Internal Medicine Residency Program at the Mayo Clinic in Florida.

His dedication to education has been recognized with the Mayo Clinic Educator Achievement Award, Course Educator of the Year Award and Mayo Clinic Internal Medicine Community Service Award. He has served in multiple leadership roles at the Mayo Clinic, including member of the Board of Governors, Chair of the Strategic Planning Committee, Chair of the Diversity Committee and Chair of the Quality Committee, among others. He is the past President of the Florida Society of Clinical Oncology. He also serves as a member of the American Board of Internal Medicine Hematology Board, and on the Board of Directors of Community Hospice Northeast in Jacksonville, Florida.

Dr. Colon-Otero graduated magna cum laude from the University of Puerto Rico with a bachelor's degree in mathematics and obtained his medical degree from the University of Puerto Rico School of Medicine with election to Alpha Omega Alpha Honor Medical Society. He completed an internship and residency in internal medicine and a fellowship in hematology at the Mayo Clinic in Rochester, Minnesota as well as a fellowship in hematology and medical oncology at the University of Virginia.

As of January 2017, Dr. Colon-Otero reported the following external relationships:

Funding for clinical trial expenses, staff and salary support, paid to the Mayo Clinic, from the following company:

  • Novartis, for an investigator initiated Phase 2 trial of everolimus and letrozole in patients with ovarian cancer.

Dr. Colon-Otero reported receiving financial support, paid to the Mayo Clinic, from unrestricted educational grants from multiple pharmaceutical companies, for the Mayo Clinic's Annual Update in Hematology and Oncology.

He also reported receiving financial support, paid to the Florida Society of Clinical Oncology, from unrestricted educational grants from multiple pharmaceutical companies, for the annual Business of Oncology meeting in Puerto Rico, sponsored by the Florida Society of Clinical Oncology.

Dr. Colon-Otero serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • Florida Society of Clinical Oncology, President and Immediate Past President, without compensation.
  • Community Hospice Northeast, Board of Directors, without compensation.

Funding from other non-profit organizations for project expenses and salary support, paid to the Mayo Clinic:

  • Robert Wood Johnson Foundation, for a health policy scholars training program in collaboration with Johns Hopkins, UCLA and University of Michigan.

Elda A. Ford, MS

Ms. Ford served as the Associate Clinical Division Administrator for the Division of Hematology/Oncology at the University of Pennsylvania for 17 years. She was responsible for providing leadership, growth and administration of operations to ensure division and department goals and objectives. She was the liaison for the physicians and the Associate Directors of the Cancer Center to direct the clinical practice operations. She also had the responsibility to oversee staff, space and facilities management and was involved in program planning with accountability for ensuring that programmatic objectives of the division were met. Currently, she serves as a member of the American Board of Internal Medicine Hematology Board.

She was additionally responsible for all aspects of the Bone Marrow and Stem Cell Transplant Program in conjunction with the Director of the Bone Marrow Transplant Program and the Divisional Administrator. Her responsibilities included evaluating external programs, and she was instrumental in implementing policies and procedures that enhanced the efficiency of the program. She served as a member of the Cancer Center Quality Committee and has served on many committees that support Business Development & Affiliation and Marketing in partnering with affiliates to develop mutually beneficial clinical, operational and marketing plans and programs.

Ms. Ford earned her nursing diploma at Saint Agnes Hospital School of Nursing. She earned her bachelor's degree and master's degree in health administration from Eastern University.

As of January 2017, Ms. Ford reported no external relationships.

Scott D. Gitlin, MD

Dr. Gitlin, a board certified internist and hematologist, is an Associate Professor of Internal Medicine in the Division of Hematology/Oncology at the University of Michigan Medical Center and at the Veterans Affairs Ann Arbor Healthcare System. His academic activities and interests include laboratory and clinical/translational research projects, the care of patients with malignant and non-malignant hematology disorders and education and training of physicians and junior faculty.

Currently, Dr. Gitlin serves as a member of the American Board of Internal Medicine Hematology Board and is an Administrative Board member of the Association of American Medical Colleges' Council of Faculty and Academic Societies. He is past member of the Board of Directors of the Alliance for Academic Internal Medicine (AAIM) and past President of the Association of Specialty Professors (ASP). He has served as Chair of the Hematology In-training Examination Test Writing Subcommittee of the American Society of Hematology. He is the 2014 recipient of the ASP/AAIM Eric G. Neilson, MD, Distinguished Professor Award. Dr. Gitlin has also had lead roles with the American Society of Hematology in the development of national and international mentoring, education and training programs for fellows and junior faculty who are interested in pursuing academic research careers.

Dr. Gitlin earned his medical degree at the University of Michigan Medical School. He did his residency in the Department of Internal Medicine at the University of Michigan and later completed his hematology/oncology fellowship training at the University of Michigan and the National Cancer Institute of the National Institutes of Health.

As of January 2017, Dr. Gitlin reported the following external relationships:

Dr. Gitlin received funding from Alexion to support expenses associated with enrollment of patients and reporting of clinical data for a clinical registry.

Dr. Gitlin serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • Association of American Medical Colleges, Chair-Elect of the Council of Faculty and Academic Societies and member of the Board of Directors, receiving reimbursement for travel expenses.

William P. Hammond, MD

Dr. Hammond is Clinical Professor of Medicine, Division of Medical Oncology, at the Seattle Cancer Care Alliance and the University of Washington School of Medicine. He is board certified in Internal Medicine, Hematology and Medical Oncology. His current position is to assist in developing a community-based component to the hematology/oncology fellowship program of the University of Washington.

Dr. Hammond most recently served as President of Minor & James Medical, PLLC, a multi-specialty group in Seattle where he practiced for 11 years. He previously served as President and CEO of the Hope Heart Institute, a cardiovascular research organization. Dr. Hammond began his career on the faculty of the University of Washington School of Medicine where his research focused on the stem cell biology of cyclic neutropenia. He then turned to educational efforts, chairing the course on hematology, developing problem-based learning for the second-year curriculum and serving as Director of Medical Education for Providence Seattle Medical Center, the University of Washington's primary community teaching hospital.

Currently, Dr. Hammond is a member of the American Board of Internal Medicine Hematology Board and serves on the Board and Executive Committee of the Puget Sound Blood Center in Seattle, where he chairs the Quality Advocacy Committee. He has served on multiple boards and is a member of the Rotary Club of Seattle.

Dr. Hammond is a graduate of Harvard College and the Tufts University School of Medicine in Boston, and completed his internship, residency and fellowship in hematology and medical oncology at the University of Washington in Seattle.

As of January 2017, Dr. Hammond reported no external relationships.

Jennifer K. Morgan, MD

Dr. Morgan is a board certified hematologist and medical oncologist. She provides care for patients through the community-based Indiana University Central Indiana Cancer Centers where she has worked since completion of her training.

Previously, Dr. Morgan served for three years as Medical Director for the Charlottesville Free Clinic.

She is a member of the American Board of Internal Medicine Hematology Board. She has also served on a variety of hospital committees, most recently as a member of the Indiana University Hospital North Pharmaceuticals and Therapeutics Committee.

Dr. Morgan earned her medical degree and was inducted to Alpha Omega Alpha Honor Medical Society at Howard University Medical College. She completed her residency in the Department of Medicine at the University of Virginia Health Sciences followed by fellowship in hematology/oncology, also at the University of Virginia.

As of January 2017, Dr. Morgan reported no external relationships.

Marc S. Zumberg, MD

Dr. Zumberg is Professor and Section Chief Non-Malignant Hematology at the University of Florida College of Medicine, Gainesville, Florida. He is board certified in Hematology.

Dr. Zumberg has been a faculty member at the University of Florida since completing his combined fellowship in Hematology and Medical Oncology in 2000. He currently serves as Professor of Medicine and as Section Chief of Non-Malignant Hematology. From 2006-2014, he served as Associate Professor of Medicine and from 2000-2006, as Assistant Professor of Medicine. Dr. Zumberg has served as Medical Director for Therapeutic Apheresis for LifeSouth Community Blood Centers since 2000.

Dr. Zumberg served on the American Society of Hematology (ASH) committee on training programs from 2008-2015. He served as the ASH liaison on Maintenance of Certification to the American Board of Internal Medicine (ABIM) Hematology Board from 2015-2017, and currently serves as a member of the ABIM Hematology Board. He was an inaugural faculty member at the ASH Medical Educators Institute (MEI) where he continues to serve as faculty. He was recognized as the basic science teacher of the year at the University of Florida Medical School in 2017 and the hematology course he directs was voted best basic science course by the graduating medical students in 2016 and 2017.

Dr. Zumberg received a bachelor's degree in neurobiology in 1990 and his medical degree in 1994, both from the University of Michigan. He completed an internal medicine residency in 1997 and a hematology-oncology fellowship in 2000, both at the University of Florida.

As of July 2017, Dr. Zumberg reported the following external relationships.

Dr. Zumberg serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • American Society of Hematology, faculty member for the first annual Medical Educators Institute, receiving consulting fees and reimbursement for travel expenses.

Dr. Zumberg is also a medical director for NCF Diagnostics & DNA Technologies.